Is Trichomonas vaginalis considered a sexually transmitted infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Trichomonas a Sexually Transmitted Infection?

Yes, Trichomonas vaginalis is definitively classified as a sexually transmitted infection (STI). 1, 2, 3

Classification and Transmission

  • The CDC explicitly categorizes trichomoniasis as a sexually transmitted disease with potentially serious sequelae, requiring simultaneous treatment of sexual partners to prevent reinfection. 3

  • The infection is highly contagious between sexual partners, with approximately 72% of male partners of infected women testing positive for concordant infection. 4

  • Women who have never been sexually active are rarely affected, supporting the sexual transmission route. 1

Clinical Significance as an STI

The classification as an STI is reinforced by several key characteristics:

  • Trichomoniasis facilitates HIV transmission and acquisition, increases risk of cervical cancer, and causes adverse pregnancy outcomes including preterm delivery and low birth weight. 2, 5

  • The infection affects an estimated 3.7 million people in the United States, making it likely the most prevalent non-viral STI. 5

  • Significant health disparities exist, with African Americans being more than 4 times more likely to be infected than other racial groups. 5

The "Hidden Reservoir" Problem

  • Approximately 80% of infected men are asymptomatic, creating a substantial reservoir for ongoing transmission without their knowledge. 6, 2

  • Up to 50% of infected women may also be asymptomatic, further complicating transmission control. 1, 2

  • This high rate of asymptomatic infection in both sexes makes screening and partner notification critical public health interventions. 6

Partner Management Requirements

  • Concurrent testing and treatment of all sexual partners is mandatory to prevent reinfection, as reinfection rates are extremely high when partners are not treated simultaneously. 2, 3

  • Patients must abstain from sexual activity until both they and their partners complete treatment and are asymptomatic. 2

Screening Recommendations

  • Women diagnosed with T. vaginalis should be screened for other STIs including Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, and HIV, as co-infections are common. 7

  • Re-testing at 3 months after treatment is recommended due to high reinfection rates. 7, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trichomonas Transmission from One Sexual Interaction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Guideline

Testing and Diagnosis of *Trichomonas vaginalis* in Men

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline for Concurrent STI Screening in Women with Confirmed Trichomonas vaginalis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.